SPOTLIGHT -
Potential COVID-19 treatment: Effective, cheap, available
A team of investigators at McMaster University in Toronto has found that fluvoxamine reduced hospitalizations by up to 30 percent.
Read More
Partial visual function restored in patient with retinitis pigmentosa
In PIONEER study, investigators outline their successes.
Optimizing the management of DED
Experts provide perspectives on current care and pipeline products.
Vaccination, positive COVID-19 test could lead to increased risk of arterial thrombotic events
A team of UK researchers further examine the rare thrombocytopenia and thromboembolic events occurring after COVID-19 vaccinations.
Phase 1 trial shows NGM621 for GA is well tolerated by study participants
Investigation evaluates safety of single and multiple intravitreal injections.
Early Phase 2 data with high-dose aflibercept promising in wet AMD
Regeneron Pharmaceuticals announced at an ongoing Phase 2 trial has met its primary safety endpoint with no new safety signals observed.
Corneal keratometry and corneal astigmatism changes after surgery for acquired ptosis
Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.
Physicians measure contrast sensitivity in patients with cataract
Advances help gain clearer image, enhancing decision-making process.
Physiologic effects of the SARS-CoV-2 virus
Investigators study the systemic adverse physiologic effects of the virus that causes COVID-19.
EURETINA 2021 offers virtual education for retina specialists
The EURETINA 2021 Virtual Meeting is scheduled for Sept. 9 to 12, and retina specialists eagerly await the showcase of cutting-edge scientific developments.
Considering older age, high BMI as risks for blepharoptosis in Korean patients
A study suggests that for the general population, evaluation for blepharoptosis should be done at 66 years of age, or at 63 and 70 years for males and females, separately.
Advent of faster, less complex COVID-19 test
Scientists have developed a new approach that is less complex and does not require extracting the genetic RNA material of the virus.
Addressing GA by downregulating overactive complement system
GT005 designed to induce local production of recombinant complement factor I.
Choroidal hypertransmission defects on en face OCT imaging predict geographic atrophy in patients
Philip Rosenfeld, MD, PhD, presents results from a natural history study of patients that results in recognition of hypertransmission defects on en face OCT.
CRISPR technology: A hot topic in gene therapy
Cotargeted therapy could help combat inherited retinal diseases.
VA and visual function go the way of ocular inflammation
Tool for quantifying measures may predict outcomes for patients.
Bariatric surgery may lead to decreased risk of cataract
Substantial weight loss can help patients’ eye health, study results show.
FDA approves cyclosporine A eye drop for vernal keratoconjunctivitis
Most patients with allergic disorder are children, adolescents, or young adults.
Inhalable COVID-19 treatment shows potentially lower viral transmission in animal studies
Llama nanobodies may be key to beating COVID-19 variants.
Survey sheds light on glaucoma prevalence in West Africa
Region may have world’s highest rate, investigators say.
New Horizons Forum: Diagnostic advances in glaucoma
Investigators from various companies described their diagnostic offerings at the Glaucoma Research Foundation’s 2021 New Horizons Forum.
Targeting gene therapy for achromatopsia
Clinical trials show subretinal agents are safe, well tolerated by patients.
Teleglaucoma: Practice survival in the COVID-19 era
Telemedicine provides readiness in time of crisis.
Postmortem study finds SARS-CoV-2 virus in the retina
The study's finding suggest that the particles may be involved in some of the ocular clinical manifestations of the COVID-19 infection.
Blepharoptosis: Unraveling this not-so-simple disorder
Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.
Gene therapy sparks foveal morphologic changes in LCA
As soon as 2 weeks after treatment, changes occur to foveal layer.
Novel therapeutic approach offers nonsurgical option for acquired blepharoptosis
Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.
Retinal imaging plays diagnostic role in COVID-19 cases
Investigators have found that optical coherence tomography findings could prove to be a diagnostic tool for COVID-19.
Phase 2/3 results show teprotumumab effective treatment option for TED
Sustained findings over long term indicate no rebound of disease.
Grail Study shows refractive stability of Juvene IOL
Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.